Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESOLVE II: S8 Sinus Implant for Chronic Sinusitis
NCT02291549Phase 3Completed
- Sponsor
- Intersect ENT
- Start
- Dec 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mometasone furoate nasal spray in sinusitis and nasal polyps (2 arms), sponsored by Intersect ENT. Primary endpoints: Nasal Obstruction/Congestion Score at 30 days and Bilateral Polyp Grade at 90 days. Started Dec 2014; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
sinusitisnasal polyps
Beyond the preview
Go deeper on NCT02291549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291549.